Hologic, Inc. (NASDAQ: HOLX) Stock Competitors & Peer Comparison
See HOLX's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Instruments & Supplies Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for HOLX and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| HOLX | $76.01 | +0.00% | 17B | 31.54 | $2.41 | N/A |
| ISRG | $385.13 | +1.90% | 133.2B | 39.21 | $9.62 | N/A |
| BDXA | $59.24 | -2.24% | 55.9B | 45.70 | $1.30 | +2.13% |
| BDX | $184.20 | +0.71% | 51.2B | 14.30 | $13.00 | +2.13% |
| RMD | $227.67 | +2.10% | 33.3B | 21.32 | $10.77 | +1.06% |
| MDLN | $33.50 | +2.78% | 27.2B | 23.53 | $1.36 | N/A |
| WST | $361.98 | +1.91% | 25.7B | 42.93 | $8.50 | +0.24% |
| SOLV | $90.53 | +0.79% | 15.6B | 12.69 | $7.10 | N/A |
| BDXB | $48.16 | +1.39% | 13.7B | 7.60 | $6.33 | +2.13% |
| BAX | $23.52 | -1.42% | 12.3B | 11.39 | $2.08 | +0.17% |
Stock Comparison
Intuitive Surgical, Inc. (NASDAQ: ISRG)
HOLX vs ISRG Comparison September 2026
Hologic, Inc. (NASDAQ: HOLX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HOLX stands at 17B. In comparison, ISRG has a market cap of 133.2B. Regarding current trading prices, HOLX is priced at $76.01 on the NASDAQ, while ISRG trades at $385.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HOLX currently has a P/E ratio of 31.54, whereas ISRG's P/E ratio is 39.21. In terms of profitability, HOLX's ROE is +0.11%, compared to ISRG's ROE of +0.18%. Regarding short-term risk, HOLX is less volatile compared to ISRG. This indicates lower risk in terms of short-term price fluctuations for HOLX.Check ISRG's competition here
Becton, Dickinson and Company (NYSE: BDXA)
HOLX vs BDXA Comparison September 2026
Hologic, Inc. (NASDAQ: HOLX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HOLX stands at 17B. In comparison, BDXA has a market cap of 55.9B. Regarding current trading prices, HOLX is priced at $76.01 on the NASDAQ, while BDXA trades at $59.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HOLX currently has a P/E ratio of 31.54, whereas BDXA's P/E ratio is 45.70. In terms of profitability, HOLX's ROE is +0.11%, compared to BDXA's ROE of +0.04%. Regarding short-term risk, HOLX is less volatile compared to BDXA. This indicates lower risk in terms of short-term price fluctuations for HOLX.Check BDXA's competition here
Becton, Dickinson and Company (NYSE: BDX)
HOLX vs BDX Comparison September 2026
Hologic, Inc. (NASDAQ: HOLX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HOLX stands at 17B. In comparison, BDX has a market cap of 51.2B. Regarding current trading prices, HOLX is priced at $76.01 on the NASDAQ, while BDX trades at $184.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HOLX currently has a P/E ratio of 31.54, whereas BDX's P/E ratio is 14.30. In terms of profitability, HOLX's ROE is +0.11%, compared to BDX's ROE of +0.04%. Regarding short-term risk, HOLX is less volatile compared to BDX. This indicates lower risk in terms of short-term price fluctuations for HOLX.Check BDX's competition here
ResMed Inc. (NYSE: RMD)
HOLX vs RMD Comparison September 2026
Hologic, Inc. (NASDAQ: HOLX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HOLX stands at 17B. In comparison, RMD has a market cap of 33.3B. Regarding current trading prices, HOLX is priced at $76.01 on the NASDAQ, while RMD trades at $227.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HOLX currently has a P/E ratio of 31.54, whereas RMD's P/E ratio is 21.32. In terms of profitability, HOLX's ROE is +0.11%, compared to RMD's ROE of +0.24%. Regarding short-term risk, HOLX is less volatile compared to RMD. This indicates lower risk in terms of short-term price fluctuations for HOLX.Check RMD's competition here
Medline Inc. (NASDAQ: MDLN)
HOLX vs MDLN Comparison September 2026
Hologic, Inc. (NASDAQ: HOLX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HOLX stands at 17B. In comparison, MDLN has a market cap of 27.2B. Regarding current trading prices, HOLX is priced at $76.01 on the NASDAQ, while MDLN trades at $33.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HOLX currently has a P/E ratio of 31.54, whereas MDLN's P/E ratio is 23.53. In terms of profitability, HOLX's ROE is +0.11%, compared to MDLN's ROE of +0.05%. Regarding short-term risk, HOLX is less volatile compared to MDLN. This indicates lower risk in terms of short-term price fluctuations for HOLX.Check MDLN's competition here
West Pharmaceutical Services, Inc. (NYSE: WST)
HOLX vs WST Comparison September 2026
Hologic, Inc. (NASDAQ: HOLX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HOLX stands at 17B. In comparison, WST has a market cap of 25.7B. Regarding current trading prices, HOLX is priced at $76.01 on the NASDAQ, while WST trades at $361.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HOLX currently has a P/E ratio of 31.54, whereas WST's P/E ratio is 42.93. In terms of profitability, HOLX's ROE is +0.11%, compared to WST's ROE of +0.19%. Regarding short-term risk, HOLX is less volatile compared to WST. This indicates lower risk in terms of short-term price fluctuations for HOLX.Check WST's competition here
Solventum Corporation (NYSE: SOLV)
HOLX vs SOLV Comparison September 2026
Hologic, Inc. (NASDAQ: HOLX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HOLX stands at 17B. In comparison, SOLV has a market cap of 15.6B. Regarding current trading prices, HOLX is priced at $76.01 on the NASDAQ, while SOLV trades at $90.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HOLX currently has a P/E ratio of 31.54, whereas SOLV's P/E ratio is 12.69. In terms of profitability, HOLX's ROE is +0.11%, compared to SOLV's ROE of +0.29%. Regarding short-term risk, HOLX is less volatile compared to SOLV. This indicates lower risk in terms of short-term price fluctuations for HOLX.Check SOLV's competition here
Becton, Dickinson and Company (NYSE: BDXB)
HOLX vs BDXB Comparison September 2026
Hologic, Inc. (NASDAQ: HOLX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HOLX stands at 17B. In comparison, BDXB has a market cap of 13.7B. Regarding current trading prices, HOLX is priced at $76.01 on the NASDAQ, while BDXB trades at $48.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HOLX currently has a P/E ratio of 31.54, whereas BDXB's P/E ratio is 7.60. In terms of profitability, HOLX's ROE is +0.11%, compared to BDXB's ROE of +0.04%. Regarding short-term risk, HOLX is less volatile compared to BDXB. This indicates lower risk in terms of short-term price fluctuations for HOLX.Check BDXB's competition here
Baxter International Inc. (NYSE: BAX)
HOLX vs BAX Comparison September 2026
Hologic, Inc. (NASDAQ: HOLX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HOLX stands at 17B. In comparison, BAX has a market cap of 12.3B. Regarding current trading prices, HOLX is priced at $76.01 on the NASDAQ, while BAX trades at $23.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HOLX currently has a P/E ratio of 31.54, whereas BAX's P/E ratio is 11.39. In terms of profitability, HOLX's ROE is +0.11%, compared to BAX's ROE of -0.17%. Regarding short-term risk, HOLX is less volatile compared to BAX. This indicates lower risk in terms of short-term price fluctuations for HOLX.Check BAX's competition here
Avantor, Inc. (NYSE: AVTR)
HOLX vs AVTR Comparison September 2026
Hologic, Inc. (NASDAQ: HOLX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HOLX stands at 17B. In comparison, AVTR has a market cap of 10.4B. Regarding current trading prices, HOLX is priced at $76.01 on the NASDAQ, while AVTR trades at $15.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HOLX currently has a P/E ratio of 31.54, whereas AVTR's P/E ratio is 18.15. In terms of profitability, HOLX's ROE is +0.11%, compared to AVTR's ROE of -0.10%. Regarding short-term risk, HOLX is less volatile compared to AVTR. This indicates lower risk in terms of short-term price fluctuations for HOLX.Check AVTR's competition here
The Cooper Companies, Inc. (NASDAQ: COO)
HOLX vs COO Comparison September 2026
Hologic, Inc. (NASDAQ: HOLX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HOLX stands at 17B. In comparison, COO has a market cap of 10.4B. Regarding current trading prices, HOLX is priced at $76.01 on the NASDAQ, while COO trades at $54.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HOLX currently has a P/E ratio of 31.54, whereas COO's P/E ratio is 11.68. In terms of profitability, HOLX's ROE is +0.11%, compared to COO's ROE of +0.07%. Regarding short-term risk, HOLX is less volatile compared to COO. This indicates lower risk in terms of short-term price fluctuations for HOLX.Check COO's competition here
Repligen Corporation (NASDAQ: RGEN)
HOLX vs RGEN Comparison September 2026
Hologic, Inc. (NASDAQ: HOLX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HOLX stands at 17B. In comparison, RGEN has a market cap of 9.9B. Regarding current trading prices, HOLX is priced at $76.01 on the NASDAQ, while RGEN trades at $174.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HOLX currently has a P/E ratio of 31.54, whereas RGEN's P/E ratio is 97.07. In terms of profitability, HOLX's ROE is +0.11%, compared to RGEN's ROE of +0.02%. Regarding short-term risk, HOLX is less volatile compared to RGEN. This indicates lower risk in terms of short-term price fluctuations for HOLX.Check RGEN's competition here
AptarGroup, Inc. (NYSE: ATR)
HOLX vs ATR Comparison September 2026
Hologic, Inc. (NASDAQ: HOLX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HOLX stands at 17B. In comparison, ATR has a market cap of 8B. Regarding current trading prices, HOLX is priced at $76.01 on the NASDAQ, while ATR trades at $125.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HOLX currently has a P/E ratio of 31.54, whereas ATR's P/E ratio is 21.79. In terms of profitability, HOLX's ROE is +0.11%, compared to ATR's ROE of +0.14%. Regarding short-term risk, HOLX is less volatile compared to ATR. This indicates lower risk in terms of short-term price fluctuations for HOLX.Check ATR's competition here
Bausch + Lomb Corporation (NYSE: BLCO)
HOLX vs BLCO Comparison September 2026
Hologic, Inc. (NASDAQ: HOLX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HOLX stands at 17B. In comparison, BLCO has a market cap of 6.2B. Regarding current trading prices, HOLX is priced at $76.01 on the NASDAQ, while BLCO trades at $17.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HOLX currently has a P/E ratio of 31.54, whereas BLCO's P/E ratio is 26.52. In terms of profitability, HOLX's ROE is +0.11%, compared to BLCO's ROE of -0.03%. Regarding short-term risk, HOLX is less volatile compared to BLCO. This indicates lower risk in terms of short-term price fluctuations for HOLX.Check BLCO's competition here
Stevanato Group S.p.A. (NYSE: STVN)
HOLX vs STVN Comparison September 2026
Hologic, Inc. (NASDAQ: HOLX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HOLX stands at 17B. In comparison, STVN has a market cap of 5.9B. Regarding current trading prices, HOLX is priced at $76.01 on the NASDAQ, while STVN trades at $21.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HOLX currently has a P/E ratio of 31.54, whereas STVN's P/E ratio is 32.57. In terms of profitability, HOLX's ROE is +0.11%, compared to STVN's ROE of +0.09%. Regarding short-term risk, HOLX is less volatile compared to STVN. This indicates lower risk in terms of short-term price fluctuations for HOLX.Check STVN's competition here
Teleflex Incorporated (NYSE: TFX)
HOLX vs TFX Comparison September 2026
Hologic, Inc. (NASDAQ: HOLX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HOLX stands at 17B. In comparison, TFX has a market cap of 5.7B. Regarding current trading prices, HOLX is priced at $76.01 on the NASDAQ, while TFX trades at $129.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HOLX currently has a P/E ratio of 31.54, whereas TFX's P/E ratio is 14.75. In terms of profitability, HOLX's ROE is +0.11%, compared to TFX's ROE of -0.32%. Regarding short-term risk, HOLX is less volatile compared to TFX. This indicates lower risk in terms of short-term price fluctuations for HOLX.Check TFX's competition here
Merit Medical Systems, Inc. (NASDAQ: MMSI)
HOLX vs MMSI Comparison September 2026
Hologic, Inc. (NASDAQ: HOLX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HOLX stands at 17B. In comparison, MMSI has a market cap of 5.1B. Regarding current trading prices, HOLX is priced at $76.01 on the NASDAQ, while MMSI trades at $86.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HOLX currently has a P/E ratio of 31.54, whereas MMSI's P/E ratio is 22.04. In terms of profitability, HOLX's ROE is +0.11%, compared to MMSI's ROE of +0.09%. Regarding short-term risk, HOLX is less volatile compared to MMSI. This indicates lower risk in terms of short-term price fluctuations for HOLX.Check MMSI's competition here
Envista Holdings Corp (NYSE: NVST)
HOLX vs NVST Comparison September 2026
Hologic, Inc. (NASDAQ: HOLX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HOLX stands at 17B. In comparison, NVST has a market cap of 4B. Regarding current trading prices, HOLX is priced at $76.01 on the NASDAQ, while NVST trades at $25.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HOLX currently has a P/E ratio of 31.54, whereas NVST's P/E ratio is 16.85. In terms of profitability, HOLX's ROE is +0.11%, compared to NVST's ROE of +0.04%. Regarding short-term risk, HOLX is less volatile compared to NVST. This indicates lower risk in terms of short-term price fluctuations for HOLX.Check NVST's competition here
ICU Medical, Inc. (NASDAQ: ICUI)
HOLX vs ICUI Comparison September 2026
Hologic, Inc. (NASDAQ: HOLX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HOLX stands at 17B. In comparison, ICUI has a market cap of 3.9B. Regarding current trading prices, HOLX is priced at $76.01 on the NASDAQ, while ICUI trades at $158.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HOLX currently has a P/E ratio of 31.54, whereas ICUI's P/E ratio is 19.46. In terms of profitability, HOLX's ROE is +0.11%, compared to ICUI's ROE of +0.01%. Regarding short-term risk, HOLX is less volatile compared to ICUI. This indicates lower risk in terms of short-term price fluctuations for HOLX.Check ICUI's competition here
Pulse Biosciences, Inc. (NASDAQ: PLSE)
HOLX vs PLSE Comparison September 2026
Hologic, Inc. (NASDAQ: HOLX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HOLX stands at 17B. In comparison, PLSE has a market cap of 3.8B. Regarding current trading prices, HOLX is priced at $76.01 on the NASDAQ, while PLSE trades at $49.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HOLX currently has a P/E ratio of 31.54, whereas PLSE's P/E ratio is -46.78. In terms of profitability, HOLX's ROE is +0.11%, compared to PLSE's ROE of -0.94%. Regarding short-term risk, HOLX is less volatile compared to PLSE. This indicates lower risk in terms of short-term price fluctuations for HOLX.Check PLSE's competition here
AtriCure, Inc. (NASDAQ: ATRC)
HOLX vs ATRC Comparison September 2026
Hologic, Inc. (NASDAQ: HOLX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HOLX stands at 17B. In comparison, ATRC has a market cap of 2.9B. Regarding current trading prices, HOLX is priced at $76.01 on the NASDAQ, while ATRC trades at $56.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HOLX currently has a P/E ratio of 31.54, whereas ATRC's P/E ratio is 1745.96. In terms of profitability, HOLX's ROE is +0.11%, compared to ATRC's ROE of +0.02%. Regarding short-term risk, HOLX is less volatile compared to ATRC. This indicates lower risk in terms of short-term price fluctuations for HOLX.Check ATRC's competition here
DENTSPLY SIRONA Inc. (NASDAQ: XRAY)
HOLX vs XRAY Comparison September 2026
Hologic, Inc. (NASDAQ: HOLX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HOLX stands at 17B. In comparison, XRAY has a market cap of 2B. Regarding current trading prices, HOLX is priced at $76.01 on the NASDAQ, while XRAY trades at $10.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HOLX currently has a P/E ratio of 31.54, whereas XRAY's P/E ratio is 6.87. In terms of profitability, HOLX's ROE is +0.11%, compared to XRAY's ROE of -0.40%. Regarding short-term risk, HOLX is less volatile compared to XRAY. This indicates lower risk in terms of short-term price fluctuations for HOLX.Check XRAY's competition here
LeMaitre Vascular, Inc. (NASDAQ: LMAT)
HOLX vs LMAT Comparison September 2026
Hologic, Inc. (NASDAQ: HOLX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HOLX stands at 17B. In comparison, LMAT has a market cap of 1.8B. Regarding current trading prices, HOLX is priced at $76.01 on the NASDAQ, while LMAT trades at $80.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HOLX currently has a P/E ratio of 31.54, whereas LMAT's P/E ratio is 29.69. In terms of profitability, HOLX's ROE is +0.11%, compared to LMAT's ROE of +0.16%. Regarding short-term risk, HOLX is less volatile compared to LMAT. This indicates lower risk in terms of short-term price fluctuations for HOLX.Check LMAT's competition here
BioLife Solutions, Inc. (NASDAQ: BLFS)
HOLX vs BLFS Comparison September 2026
Hologic, Inc. (NASDAQ: HOLX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HOLX stands at 17B. In comparison, BLFS has a market cap of 1.8B. Regarding current trading prices, HOLX is priced at $76.01 on the NASDAQ, while BLFS trades at $36.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HOLX currently has a P/E ratio of 31.54, whereas BLFS's P/E ratio is -172.18. In terms of profitability, HOLX's ROE is +0.11%, compared to BLFS's ROE of +0.13%. Regarding short-term risk, HOLX is less volatile compared to BLFS. This indicates lower risk in terms of short-term price fluctuations for HOLX.Check BLFS's competition here
Azenta, Inc. (NASDAQ: AZTA)
HOLX vs AZTA Comparison September 2026
Hologic, Inc. (NASDAQ: HOLX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HOLX stands at 17B. In comparison, AZTA has a market cap of 1.5B. Regarding current trading prices, HOLX is priced at $76.01 on the NASDAQ, while AZTA trades at $33.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HOLX currently has a P/E ratio of 31.54, whereas AZTA's P/E ratio is 78.64. In terms of profitability, HOLX's ROE is +0.11%, compared to AZTA's ROE of -0.08%. Regarding short-term risk, HOLX is less volatile compared to AZTA. This indicates lower risk in terms of short-term price fluctuations for HOLX.Check AZTA's competition here
Kestra Medical Technologies, Ltd. (NASDAQ: KMTS)
HOLX vs KMTS Comparison September 2026
Hologic, Inc. (NASDAQ: HOLX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HOLX stands at 17B. In comparison, KMTS has a market cap of 1.5B. Regarding current trading prices, HOLX is priced at $76.01 on the NASDAQ, while KMTS trades at $24.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HOLX currently has a P/E ratio of 31.54, whereas KMTS's P/E ratio is -9.50. In terms of profitability, HOLX's ROE is +0.11%, compared to KMTS's ROE of -0.64%. Regarding short-term risk, HOLX is less volatile compared to KMTS. This indicates lower risk in terms of short-term price fluctuations for HOLX.Check KMTS's competition here
STAAR Surgical Company (NASDAQ: STAA)
HOLX vs STAA Comparison September 2026
Hologic, Inc. (NASDAQ: HOLX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HOLX stands at 17B. In comparison, STAA has a market cap of 1.1B. Regarding current trading prices, HOLX is priced at $76.01 on the NASDAQ, while STAA trades at $22.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HOLX currently has a P/E ratio of 31.54, whereas STAA's P/E ratio is 39.38. In terms of profitability, HOLX's ROE is +0.11%, compared to STAA's ROE of +0.01%. Regarding short-term risk, HOLX is less volatile compared to STAA. This indicates lower risk in terms of short-term price fluctuations for HOLX.Check STAA's competition here
Atrion Corporation (NASDAQ: ATRI)
HOLX vs ATRI Comparison September 2026
Hologic, Inc. (NASDAQ: HOLX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HOLX stands at 17B. In comparison, ATRI has a market cap of 809.4M. Regarding current trading prices, HOLX is priced at $76.01 on the NASDAQ, while ATRI trades at $459.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HOLX currently has a P/E ratio of 31.54, whereas ATRI's P/E ratio is 64.50. In terms of profitability, HOLX's ROE is +0.11%, compared to ATRI's ROE of +0.08%. Regarding short-term risk, HOLX is less volatile compared to ATRI. This indicates lower risk in terms of short-term price fluctuations for HOLX.Check ATRI's competition here
AngioDynamics, Inc. (NASDAQ: ANGO)
HOLX vs ANGO Comparison September 2026
Hologic, Inc. (NASDAQ: HOLX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HOLX stands at 17B. In comparison, ANGO has a market cap of 648.1M. Regarding current trading prices, HOLX is priced at $76.01 on the NASDAQ, while ANGO trades at $15.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HOLX currently has a P/E ratio of 31.54, whereas ANGO's P/E ratio is -40.21. In terms of profitability, HOLX's ROE is +0.11%, compared to ANGO's ROE of -0.21%. Regarding short-term risk, HOLX is less volatile compared to ANGO. This indicates lower risk in terms of short-term price fluctuations for HOLX.Check ANGO's competition here
Sanara MedTech Inc. (NASDAQ: SMTI)
HOLX vs SMTI Comparison September 2026
Hologic, Inc. (NASDAQ: HOLX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HOLX stands at 17B. In comparison, SMTI has a market cap of 322.8M. Regarding current trading prices, HOLX is priced at $76.01 on the NASDAQ, while SMTI trades at $35.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HOLX currently has a P/E ratio of 31.54, whereas SMTI's P/E ratio is -585.17. In terms of profitability, HOLX's ROE is +0.11%, compared to SMTI's ROE of -4.74%. Regarding short-term risk, HOLX is less volatile compared to SMTI. This indicates lower risk in terms of short-term price fluctuations for HOLX.Check SMTI's competition here
Embecta Corp. (NASDAQ: EMBC)
HOLX vs EMBC Comparison September 2026
Hologic, Inc. (NASDAQ: HOLX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HOLX stands at 17B. In comparison, EMBC has a market cap of 302M. Regarding current trading prices, HOLX is priced at $76.01 on the NASDAQ, while EMBC trades at $5.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HOLX currently has a P/E ratio of 31.54, whereas EMBC's P/E ratio is 1.96. In terms of profitability, HOLX's ROE is +0.11%, compared to EMBC's ROE of -0.14%. Regarding short-term risk, HOLX is less volatile compared to EMBC. This indicates lower risk in terms of short-term price fluctuations for HOLX.Check EMBC's competition here
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN)
HOLX vs NNNN Comparison September 2026
Hologic, Inc. (NASDAQ: HOLX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HOLX stands at 17B. In comparison, NNNN has a market cap of 241.8M. Regarding current trading prices, HOLX is priced at $76.01 on the NASDAQ, while NNNN trades at $5.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HOLX currently has a P/E ratio of 31.54, whereas NNNN's P/E ratio is 79.62. In terms of profitability, HOLX's ROE is +0.11%, compared to NNNN's ROE of +0.27%. Regarding short-term risk, HOLX is less volatile compared to NNNN. This indicates lower risk in terms of short-term price fluctuations for HOLX.Check NNNN's competition here
OraSure Technologies, Inc. (NASDAQ: OSUR)
HOLX vs OSUR Comparison September 2026
Hologic, Inc. (NASDAQ: HOLX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HOLX stands at 17B. In comparison, OSUR has a market cap of 238.2M. Regarding current trading prices, HOLX is priced at $76.01 on the NASDAQ, while OSUR trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HOLX currently has a P/E ratio of 31.54, whereas OSUR's P/E ratio is -5.01. In terms of profitability, HOLX's ROE is +0.11%, compared to OSUR's ROE of -0.15%. Regarding short-term risk, HOLX is less volatile compared to OSUR. This indicates lower risk in terms of short-term price fluctuations for HOLX.Check OSUR's competition here
Utah Medical Products, Inc. (NASDAQ: UTMD)
HOLX vs UTMD Comparison September 2026
Hologic, Inc. (NASDAQ: HOLX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HOLX stands at 17B. In comparison, UTMD has a market cap of 237.6M. Regarding current trading prices, HOLX is priced at $76.01 on the NASDAQ, while UTMD trades at $74.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HOLX currently has a P/E ratio of 31.54, whereas UTMD's P/E ratio is 22.08. In terms of profitability, HOLX's ROE is +0.11%, compared to UTMD's ROE of +0.09%. Regarding short-term risk, HOLX is less volatile compared to UTMD. This indicates lower risk in terms of short-term price fluctuations for HOLX.Check UTMD's competition here
Pro-Dex, Inc. (NASDAQ: PDEX)
HOLX vs PDEX Comparison September 2026
Hologic, Inc. (NASDAQ: HOLX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HOLX stands at 17B. In comparison, PDEX has a market cap of 213.6M. Regarding current trading prices, HOLX is priced at $76.01 on the NASDAQ, while PDEX trades at $72.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HOLX currently has a P/E ratio of 31.54, whereas PDEX's P/E ratio is 16.20. In terms of profitability, HOLX's ROE is +0.11%, compared to PDEX's ROE of +0.31%. Regarding short-term risk, HOLX is less volatile compared to PDEX. This indicates lower risk in terms of short-term price fluctuations for HOLX.Check PDEX's competition here
KORU Medical Systems, Inc. (NASDAQ: KRMD)
HOLX vs KRMD Comparison September 2026
Hologic, Inc. (NASDAQ: HOLX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HOLX stands at 17B. In comparison, KRMD has a market cap of 145.1M. Regarding current trading prices, HOLX is priced at $76.01 on the NASDAQ, while KRMD trades at $3.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HOLX currently has a P/E ratio of 31.54, whereas KRMD's P/E ratio is -79.00. In terms of profitability, HOLX's ROE is +0.11%, compared to KRMD's ROE of -0.11%. Regarding short-term risk, HOLX is less volatile compared to KRMD. This indicates lower risk in terms of short-term price fluctuations for HOLX.Check KRMD's competition here
Stereotaxis, Inc. (AMEX: STXS)
HOLX vs STXS Comparison September 2026
Hologic, Inc. (NASDAQ: HOLX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HOLX stands at 17B. In comparison, STXS has a market cap of 129.3M. Regarding current trading prices, HOLX is priced at $76.01 on the NASDAQ, while STXS trades at $1.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HOLX currently has a P/E ratio of 31.54, whereas STXS's P/E ratio is -7.76. In terms of profitability, HOLX's ROE is +0.11%, compared to STXS's ROE of -1.33%. Regarding short-term risk, HOLX is less volatile compared to STXS. This indicates lower risk in terms of short-term price fluctuations for HOLX.Check STXS's competition here
Daxor Corporation (NASDAQ: DXR)
HOLX vs DXR Comparison September 2026
Hologic, Inc. (NASDAQ: HOLX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HOLX stands at 17B. In comparison, DXR has a market cap of 68M. Regarding current trading prices, HOLX is priced at $76.01 on the NASDAQ, while DXR trades at $11.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HOLX currently has a P/E ratio of 31.54, whereas DXR's P/E ratio is 9.47. In terms of profitability, HOLX's ROE is +0.11%, compared to DXR's ROE of +0.13%. Regarding short-term risk, HOLX is less volatile compared to DXR. This indicates lower risk in terms of short-term price fluctuations for HOLX.Check DXR's competition here
Akoya Biosciences, Inc. (NASDAQ: AKYA)
HOLX vs AKYA Comparison September 2026
Hologic, Inc. (NASDAQ: HOLX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HOLX stands at 17B. In comparison, AKYA has a market cap of 64.4M. Regarding current trading prices, HOLX is priced at $76.01 on the NASDAQ, while AKYA trades at $1.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HOLX currently has a P/E ratio of 31.54, whereas AKYA's P/E ratio is -1.34. In terms of profitability, HOLX's ROE is +0.11%, compared to AKYA's ROE of -1.80%. Regarding short-term risk, HOLX is similarly volatile compared to AKYA. This indicates similar risk in terms of short-term price fluctuations for HOLX.Check AKYA's competition here
SkyAI, Inc. (NASDAQ: STSS)
HOLX vs STSS Comparison September 2026
Hologic, Inc. (NASDAQ: HOLX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HOLX stands at 17B. In comparison, STSS has a market cap of 53.7M. Regarding current trading prices, HOLX is priced at $76.01 on the NASDAQ, while STSS trades at $1.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HOLX currently has a P/E ratio of 31.54, whereas STSS's P/E ratio is -0.02. In terms of profitability, HOLX's ROE is +0.11%, compared to STSS's ROE of -1.54%. Regarding short-term risk, HOLX is less volatile compared to STSS. This indicates lower risk in terms of short-term price fluctuations for HOLX.Check STSS's competition here
Singular Genomics Systems, Inc. (NASDAQ: OMIC)
HOLX vs OMIC Comparison September 2026
Hologic, Inc. (NASDAQ: HOLX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HOLX stands at 17B. In comparison, OMIC has a market cap of 50.8M. Regarding current trading prices, HOLX is priced at $76.01 on the NASDAQ, while OMIC trades at $20.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HOLX currently has a P/E ratio of 31.54, whereas OMIC's P/E ratio is -0.58. In terms of profitability, HOLX's ROE is +0.11%, compared to OMIC's ROE of -0.43%. Regarding short-term risk, HOLX is less volatile compared to OMIC. This indicates lower risk in terms of short-term price fluctuations for HOLX.Check OMIC's competition here
GlucoTrack, Inc. (NASDAQ: IGAP)
HOLX vs IGAP Comparison September 2026
Hologic, Inc. (NASDAQ: HOLX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HOLX stands at 17B. In comparison, IGAP has a market cap of 50.2M. Regarding current trading prices, HOLX is priced at $76.01 on the NASDAQ, while IGAP trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HOLX currently has a P/E ratio of 31.54, whereas IGAP's P/E ratio is -10.52. In terms of profitability, HOLX's ROE is +0.11%, compared to IGAP's ROE of +1.80%. Regarding short-term risk, HOLX is less volatile compared to IGAP. This indicates lower risk in terms of short-term price fluctuations for HOLX.Check IGAP's competition here
Nephros, Inc. (NASDAQ: NEPH)
HOLX vs NEPH Comparison September 2026
Hologic, Inc. (NASDAQ: HOLX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HOLX stands at 17B. In comparison, NEPH has a market cap of 46.6M. Regarding current trading prices, HOLX is priced at $76.01 on the NASDAQ, while NEPH trades at $4.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HOLX currently has a P/E ratio of 31.54, whereas NEPH's P/E ratio is 71.50. In terms of profitability, HOLX's ROE is +0.11%, compared to NEPH's ROE of +0.16%. Regarding short-term risk, HOLX is less volatile compared to NEPH. This indicates lower risk in terms of short-term price fluctuations for HOLX.Check NEPH's competition here
Precision Optics Corporation, Inc. (NASDAQ: POCI)
HOLX vs POCI Comparison September 2026
Hologic, Inc. (NASDAQ: HOLX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HOLX stands at 17B. In comparison, POCI has a market cap of 46.1M. Regarding current trading prices, HOLX is priced at $76.01 on the NASDAQ, while POCI trades at $4.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HOLX currently has a P/E ratio of 31.54, whereas POCI's P/E ratio is -6.68. In terms of profitability, HOLX's ROE is +0.11%, compared to POCI's ROE of -0.37%. Regarding short-term risk, HOLX is less volatile compared to POCI. This indicates lower risk in terms of short-term price fluctuations for HOLX.Check POCI's competition here
Harvard Bioscience, Inc. (NASDAQ: HBIO)
HOLX vs HBIO Comparison September 2026
Hologic, Inc. (NASDAQ: HOLX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HOLX stands at 17B. In comparison, HBIO has a market cap of 36M. Regarding current trading prices, HOLX is priced at $76.01 on the NASDAQ, while HBIO trades at $8.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HOLX currently has a P/E ratio of 31.54, whereas HBIO's P/E ratio is -22.17. In terms of profitability, HOLX's ROE is +0.11%, compared to HBIO's ROE of -0.92%. Regarding short-term risk, HOLX is less volatile compared to HBIO. This indicates lower risk in terms of short-term price fluctuations for HOLX.Check HBIO's competition here
Milestone Scientific Inc. (AMEX: MLSS)
HOLX vs MLSS Comparison September 2026
Hologic, Inc. (NASDAQ: HOLX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HOLX stands at 17B. In comparison, MLSS has a market cap of 35.5M. Regarding current trading prices, HOLX is priced at $76.01 on the NASDAQ, while MLSS trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HOLX currently has a P/E ratio of 31.54, whereas MLSS's P/E ratio is -8.02. In terms of profitability, HOLX's ROE is +0.11%, compared to MLSS's ROE of -1.49%. Regarding short-term risk, HOLX is less volatile compared to MLSS. This indicates lower risk in terms of short-term price fluctuations for HOLX.Check MLSS's competition here
SmileDirectClub, Inc. (NASDAQ: SDC)
HOLX vs SDC Comparison September 2026
Hologic, Inc. (NASDAQ: HOLX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HOLX stands at 17B. In comparison, SDC has a market cap of 29.1M. Regarding current trading prices, HOLX is priced at $76.01 on the NASDAQ, while SDC trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HOLX currently has a P/E ratio of 31.54, whereas SDC's P/E ratio is -0.03. In terms of profitability, HOLX's ROE is +0.11%, compared to SDC's ROE of -1.96%. Regarding short-term risk, HOLX is less volatile compared to SDC. This indicates lower risk in terms of short-term price fluctuations for HOLX.Check SDC's competition here
Invacare Corporation (NYSE: IVC)
HOLX vs IVC Comparison September 2026
Hologic, Inc. (NASDAQ: HOLX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HOLX stands at 17B. In comparison, IVC has a market cap of 24.9M. Regarding current trading prices, HOLX is priced at $76.01 on the NASDAQ, while IVC trades at $0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HOLX currently has a P/E ratio of 31.54, whereas IVC's P/E ratio is -0.79. In terms of profitability, HOLX's ROE is +0.11%, compared to IVC's ROE of -0.46%. Regarding short-term risk, HOLX is less volatile compared to IVC. This indicates lower risk in terms of short-term price fluctuations for HOLX.Check IVC's competition here
Retractable Technologies, Inc. (AMEX: RVP)
HOLX vs RVP Comparison September 2026
Hologic, Inc. (NASDAQ: HOLX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HOLX stands at 17B. In comparison, RVP has a market cap of 20.4M. Regarding current trading prices, HOLX is priced at $76.01 on the NASDAQ, while RVP trades at $0.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HOLX currently has a P/E ratio of 31.54, whereas RVP's P/E ratio is -5.67. In terms of profitability, HOLX's ROE is +0.11%, compared to RVP's ROE of -0.05%. Regarding short-term risk, HOLX is less volatile compared to RVP. This indicates lower risk in terms of short-term price fluctuations for HOLX.Check RVP's competition here
Bionano Genomics, Inc. (NASDAQ: BNGO)
HOLX vs BNGO Comparison September 2026
Hologic, Inc. (NASDAQ: HOLX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HOLX stands at 17B. In comparison, BNGO has a market cap of 17.9M. Regarding current trading prices, HOLX is priced at $76.01 on the NASDAQ, while BNGO trades at $1.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HOLX currently has a P/E ratio of 31.54, whereas BNGO's P/E ratio is -0.36. In terms of profitability, HOLX's ROE is +0.11%, compared to BNGO's ROE of -0.79%. Regarding short-term risk, HOLX is less volatile compared to BNGO. This indicates lower risk in terms of short-term price fluctuations for HOLX.Check BNGO's competition here
Jin Medical International Ltd. (NASDAQ: ZJYL)
HOLX vs ZJYL Comparison September 2026
Hologic, Inc. (NASDAQ: HOLX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HOLX stands at 17B. In comparison, ZJYL has a market cap of 15.6M. Regarding current trading prices, HOLX is priced at $76.01 on the NASDAQ, while ZJYL trades at $1.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HOLX currently has a P/E ratio of 31.54, whereas ZJYL's P/E ratio is 13.61. In terms of profitability, HOLX's ROE is +0.11%, compared to ZJYL's ROE of +0.04%. Regarding short-term risk, HOLX is less volatile compared to ZJYL. This indicates lower risk in terms of short-term price fluctuations for HOLX.Check ZJYL's competition here
Regentis Biomaterials Ltd. (AMEX: RGNT)
HOLX vs RGNT Comparison September 2026
Hologic, Inc. (NASDAQ: HOLX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HOLX stands at 17B. In comparison, RGNT has a market cap of 12.6M. Regarding current trading prices, HOLX is priced at $76.01 on the NASDAQ, while RGNT trades at $1.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HOLX currently has a P/E ratio of 31.54, whereas RGNT's P/E ratio is -0.07. In terms of profitability, HOLX's ROE is +0.11%, compared to RGNT's ROE of N/A. Regarding short-term risk, HOLX is less volatile compared to RGNT. This indicates lower risk in terms of short-term price fluctuations for HOLX.Check RGNT's competition here
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (NASDAQ: CUPR)
HOLX vs CUPR Comparison September 2026
Hologic, Inc. (NASDAQ: HOLX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HOLX stands at 17B. In comparison, CUPR has a market cap of 7.9M. Regarding current trading prices, HOLX is priced at $76.01 on the NASDAQ, while CUPR trades at $1.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HOLX currently has a P/E ratio of 31.54, whereas CUPR's P/E ratio is -2.12. In terms of profitability, HOLX's ROE is +0.11%, compared to CUPR's ROE of -15.69%. Regarding short-term risk, HOLX is less volatile compared to CUPR. This indicates lower risk in terms of short-term price fluctuations for HOLX.Check CUPR's competition here
Femasys Inc. (NASDAQ: FEMY)
HOLX vs FEMY Comparison September 2026
Hologic, Inc. (NASDAQ: HOLX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HOLX stands at 17B. In comparison, FEMY has a market cap of 7.7M. Regarding current trading prices, HOLX is priced at $76.01 on the NASDAQ, while FEMY trades at $2.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HOLX currently has a P/E ratio of 31.54, whereas FEMY's P/E ratio is -0.57. In terms of profitability, HOLX's ROE is +0.11%, compared to FEMY's ROE of -2.26%. Regarding short-term risk, HOLX is less volatile compared to FEMY. This indicates lower risk in terms of short-term price fluctuations for HOLX.Check FEMY's competition here
Lucyd, Inc (NASDAQ: LUCY)
HOLX vs LUCY Comparison September 2026
Hologic, Inc. (NASDAQ: HOLX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HOLX stands at 17B. In comparison, LUCY has a market cap of 5.2M. Regarding current trading prices, HOLX is priced at $76.01 on the NASDAQ, while LUCY trades at $0.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HOLX currently has a P/E ratio of 31.54, whereas LUCY's P/E ratio is -0.49. In terms of profitability, HOLX's ROE is +0.11%, compared to LUCY's ROE of -0.89%. Regarding short-term risk, HOLX is less volatile compared to LUCY. This indicates lower risk in terms of short-term price fluctuations for HOLX.Check LUCY's competition here
NanoString Technologies, Inc. (NASDAQ: NSTG)
HOLX vs NSTG Comparison September 2026
Hologic, Inc. (NASDAQ: HOLX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HOLX stands at 17B. In comparison, NSTG has a market cap of 5.1M. Regarding current trading prices, HOLX is priced at $76.01 on the NASDAQ, while NSTG trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HOLX currently has a P/E ratio of 31.54, whereas NSTG's P/E ratio is -0.03. In terms of profitability, HOLX's ROE is +0.11%, compared to NSTG's ROE of -1.43%. Regarding short-term risk, HOLX is less volatile compared to NSTG. This indicates lower risk in terms of short-term price fluctuations for HOLX.Check NSTG's competition here
Predictive Oncology Inc. (NASDAQ: POAI)
HOLX vs POAI Comparison September 2026
Hologic, Inc. (NASDAQ: HOLX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HOLX stands at 17B. In comparison, POAI has a market cap of 3.6M. Regarding current trading prices, HOLX is priced at $76.01 on the NASDAQ, while POAI trades at $4.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HOLX currently has a P/E ratio of 31.54, whereas POAI's P/E ratio is -0.03. In terms of profitability, HOLX's ROE is +0.11%, compared to POAI's ROE of -21.19%. Regarding short-term risk, HOLX is less volatile compared to POAI. This indicates lower risk in terms of short-term price fluctuations for HOLX.Check POAI's competition here
Meihua International Medical Technologies Co., Ltd. (NASDAQ: MHUA)
HOLX vs MHUA Comparison September 2026
Hologic, Inc. (NASDAQ: HOLX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HOLX stands at 17B. In comparison, MHUA has a market cap of 2.4M. Regarding current trading prices, HOLX is priced at $76.01 on the NASDAQ, while MHUA trades at $7.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HOLX currently has a P/E ratio of 31.54, whereas MHUA's P/E ratio is 0.25. In terms of profitability, HOLX's ROE is +0.11%, compared to MHUA's ROE of +0.07%. Regarding short-term risk, HOLX is similarly volatile compared to MHUA. This indicates similar risk in terms of short-term price fluctuations for HOLX.Check MHUA's competition here
NEXGEL, Inc. (NASDAQ: NXGL)
HOLX vs NXGL Comparison September 2026
Hologic, Inc. (NASDAQ: HOLX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HOLX stands at 17B. In comparison, NXGL has a market cap of 2.4M. Regarding current trading prices, HOLX is priced at $76.01 on the NASDAQ, while NXGL trades at $0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HOLX currently has a P/E ratio of 31.54, whereas NXGL's P/E ratio is -0.40. In terms of profitability, HOLX's ROE is +0.11%, compared to NXGL's ROE of -1.33%. Regarding short-term risk, HOLX is less volatile compared to NXGL. This indicates lower risk in terms of short-term price fluctuations for HOLX.Check NXGL's competition here
G Medical Innovations Holdings Ltd (NASDAQ: GMVD)
HOLX vs GMVD Comparison September 2026
Hologic, Inc. (NASDAQ: HOLX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HOLX stands at 17B. In comparison, GMVD has a market cap of 1.8M. Regarding current trading prices, HOLX is priced at $76.01 on the NASDAQ, while GMVD trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HOLX currently has a P/E ratio of 31.54, whereas GMVD's P/E ratio is -0.01. In terms of profitability, HOLX's ROE is +0.11%, compared to GMVD's ROE of +2.09%. Regarding short-term risk, HOLX is less volatile compared to GMVD. This indicates lower risk in terms of short-term price fluctuations for HOLX.Check GMVD's competition here
G Medical Innovations Holdings Ltd (NASDAQ: GMVDW)
HOLX vs GMVDW Comparison September 2026
Hologic, Inc. (NASDAQ: HOLX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HOLX stands at 17B. In comparison, GMVDW has a market cap of 1.8M. Regarding current trading prices, HOLX is priced at $76.01 on the NASDAQ, while GMVDW trades at $7.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HOLX currently has a P/E ratio of 31.54, whereas GMVDW's P/E ratio is N/A. In terms of profitability, HOLX's ROE is +0.11%, compared to GMVDW's ROE of +2.09%. Regarding short-term risk, HOLX is less volatile compared to GMVDW. This indicates lower risk in terms of short-term price fluctuations for HOLX.Check GMVDW's competition here
Avinger, Inc. (NASDAQ: AVGR)
HOLX vs AVGR Comparison September 2026
Hologic, Inc. (NASDAQ: HOLX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HOLX stands at 17B. In comparison, AVGR has a market cap of 1.5M. Regarding current trading prices, HOLX is priced at $76.01 on the NASDAQ, while AVGR trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HOLX currently has a P/E ratio of 31.54, whereas AVGR's P/E ratio is -0.05. In terms of profitability, HOLX's ROE is +0.11%, compared to AVGR's ROE of +17.82%. Regarding short-term risk, HOLX is less volatile compared to AVGR. This indicates lower risk in terms of short-term price fluctuations for HOLX.Check AVGR's competition here
NEXGEL, Inc. (NASDAQ: NXGLW)
HOLX vs NXGLW Comparison September 2026
Hologic, Inc. (NASDAQ: HOLX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HOLX stands at 17B. In comparison, NXGLW has a market cap of 1.2M. Regarding current trading prices, HOLX is priced at $76.01 on the NASDAQ, while NXGLW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HOLX currently has a P/E ratio of 31.54, whereas NXGLW's P/E ratio is -0.02. In terms of profitability, HOLX's ROE is +0.11%, compared to NXGLW's ROE of -1.33%. Regarding short-term risk, HOLX is less volatile compared to NXGLW. This indicates lower risk in terms of short-term price fluctuations for HOLX.Check NXGLW's competition here
Lucyd, Inc (NASDAQ: LUCYW)
HOLX vs LUCYW Comparison September 2026
Hologic, Inc. (NASDAQ: HOLX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HOLX stands at 17B. In comparison, LUCYW has a market cap of 296.1K. Regarding current trading prices, HOLX is priced at $76.01 on the NASDAQ, while LUCYW trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HOLX currently has a P/E ratio of 31.54, whereas LUCYW's P/E ratio is N/A. In terms of profitability, HOLX's ROE is +0.11%, compared to LUCYW's ROE of -0.89%. Regarding short-term risk, HOLX is less volatile compared to LUCYW. This indicates lower risk in terms of short-term price fluctuations for HOLX.Check LUCYW's competition here
Apria, Inc. (NASDAQ: APR)
HOLX vs APR Comparison September 2026
Hologic, Inc. (NASDAQ: HOLX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HOLX stands at 17B. In comparison, APR has a market cap of 0. Regarding current trading prices, HOLX is priced at $76.01 on the NASDAQ, while APR trades at $37.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HOLX currently has a P/E ratio of 31.54, whereas APR's P/E ratio is 22.59. In terms of profitability, HOLX's ROE is +0.11%, compared to APR's ROE of +9.81%. Regarding short-term risk, HOLX is less volatile compared to APR. This indicates lower risk in terms of short-term price fluctuations for HOLX.Check APR's competition here
IntriCon Corporation (NASDAQ: IIN)
HOLX vs IIN Comparison September 2026
Hologic, Inc. (NASDAQ: HOLX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HOLX stands at 17B. In comparison, IIN has a market cap of 0. Regarding current trading prices, HOLX is priced at $76.01 on the NASDAQ, while IIN trades at $24.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HOLX currently has a P/E ratio of 31.54, whereas IIN's P/E ratio is 226.45. In terms of profitability, HOLX's ROE is +0.11%, compared to IIN's ROE of -0.00%. Regarding short-term risk, HOLX is less volatile compared to IIN. This indicates lower risk in terms of short-term price fluctuations for HOLX.Check IIN's competition here
Antares Pharma, Inc. (NASDAQ: ATRS)
HOLX vs ATRS Comparison September 2026
Hologic, Inc. (NASDAQ: HOLX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HOLX stands at 17B. In comparison, ATRS has a market cap of 0. Regarding current trading prices, HOLX is priced at $76.01 on the NASDAQ, while ATRS trades at $5.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HOLX currently has a P/E ratio of 31.54, whereas ATRS's P/E ratio is 14.95. In terms of profitability, HOLX's ROE is +0.11%, compared to ATRS's ROE of +0.31%. Regarding short-term risk, HOLX is less volatile compared to ATRS. This indicates lower risk in terms of short-term price fluctuations for HOLX.Check ATRS's competition here
Invuity, Inc. (NASDAQ: IVTY)
HOLX vs IVTY Comparison September 2026
Hologic, Inc. (NASDAQ: HOLX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HOLX stands at 17B. In comparison, IVTY has a market cap of 0. Regarding current trading prices, HOLX is priced at $76.01 on the NASDAQ, while IVTY trades at $7.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HOLX currently has a P/E ratio of 31.54, whereas IVTY's P/E ratio is -3.80. In terms of profitability, HOLX's ROE is +0.11%, compared to IVTY's ROE of -2.40%. Regarding short-term risk, HOLX is similarly volatile compared to IVTY. This indicates similar risk in terms of short-term price fluctuations for HOLX.Check IVTY's competition here
Analogic Corporation (NASDAQ: ALOG)
HOLX vs ALOG Comparison September 2026
Hologic, Inc. (NASDAQ: HOLX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HOLX stands at 17B. In comparison, ALOG has a market cap of 0. Regarding current trading prices, HOLX is priced at $76.01 on the NASDAQ, while ALOG trades at $83.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HOLX currently has a P/E ratio of 31.54, whereas ALOG's P/E ratio is 40.93. In terms of profitability, HOLX's ROE is +0.11%, compared to ALOG's ROE of -0.15%. Regarding short-term risk, HOLX is similarly volatile compared to ALOG. This indicates similar risk in terms of short-term price fluctuations for HOLX.Check ALOG's competition here
Hill-Rom Holdings, Inc. (NYSE: HRC)
HOLX vs HRC Comparison September 2026
Hologic, Inc. (NASDAQ: HOLX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HOLX stands at 17B. In comparison, HRC has a market cap of 0. Regarding current trading prices, HOLX is priced at $76.01 on the NASDAQ, while HRC trades at $155.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HOLX currently has a P/E ratio of 31.54, whereas HRC's P/E ratio is 41.92. In terms of profitability, HOLX's ROE is +0.11%, compared to HRC's ROE of +0.14%. Regarding short-term risk, HOLX is less volatile compared to HRC. This indicates lower risk in terms of short-term price fluctuations for HOLX.Check HRC's competition here